Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration-Reference-Cited by-同舟云学术

Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration

Published:2020-01-24 Issue:10 Volume:34 Page:1888-1896
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Chandra Shruti^ORCID,Arpa Cristina,Menon Deepthy,Khalid Hagar^ORCID,Hamilton Robin,Nicholson Luke,Pal Bishwanath,Fasolo Sandro,Hykin Philip,Keane Pearse A.,Sivaprasad Sobha

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://www.nature.com/articles/s41433-020-0764-9.pdf

Reference21 articles.

1. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–31.

2. Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology. 2005;112:1035–47.

3. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology. 2009;116:57–65.e5.

4. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119:2537–48.

5. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Maguire MG, Martin DF, Ying GS, Jaffe GJ, Daniel E, Grunwald JE, et al. Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2016;123:1751–61.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration;British Journal of Ophthalmology;2024-07-20

2. Treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor drugs: progress from mechanisms to clinical applications;Frontiers in Medicine;2024-07-19

3. Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema;Clinical Ophthalmology;2024-05

4. Estrogen related receptor alpha: Potential modulator of age-related macular degeneration;Current Opinion in Pharmacology;2024-04

5. Recent Advances in Our Understanding of Age-Related Macular Degeneration: Mitochondrial Dysfunction, Redox Signaling, and the Complement System;aging and disease;2024